Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,793,111
-
Share change
-
-37,195
-
Total reported value
-
$109,371,210
-
Price per share
-
$39.15
-
Number of holders
-
77
-
Value change
-
-$1,340,150
-
Number of buys
-
38
-
Number of sells
-
36
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q1 2015
As of 31 Mar 2015,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,793,111 shares.
The largest 10 holders included
ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, NORTHPOINTE CAPITAL LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, WELLS FARGO & COMPANY/MN, BlackRock Institutional Trust Company, N.A., and Allianz Asset Management AG.
This page lists
77
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.